Navigation Links
Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2007 Financial Results
Date:10/29/2007

SAN DIEGO, Oct. 29 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its third quarter 2007 financial results after the Nasdaq market closes on Thursday, November 1, 2007. A live conference call and webcast will be held at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

Participants can access the live conference call by dialing 1-800-894-5910, (US) or 785-424-1052 (International) using the conference ID: 7NBIX. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com

If you are unable to attend the Webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 1-800-727-5306 (US) or 402-220-2670 (International) using the conference ID: 7NBIX. The call will be archived for two weeks.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. The product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, irritable bowel syndrome, endometriosis and CNS related disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Inc. (Nasdaq: OSTE ), a leader in ... healing, announced today that it has submitted a ... Drug Administration (FDA) to obtain marketing clearance for ... repair or replace the dura mater (the outermost ... procedures. This filing is based, in part, ...
(Date:12/17/2009)... /PRNewswire-Asia/ -- Using a novel stem cell based,technology ... eliminate a glioma -- brain cancer -- of ... in Beijing. The treatment shows that the activated,immune ... well as cancer daughter,cells. The amazing outcome of ... Cellonis that the future vaccination therapies may be,targeted ...
(Date:12/17/2009)... rise the U.S. in November, even as the overall unemployment rate ... in the pharmaceutical industry. , ... (Vocus) December 17, ... job losses - which is to say, there were no ... area was related to the Pfizer acquisition of Wyeth. Meanwhile, healthcare ...
(Date:12/17/2009)... the Daveys, the GLOBALS, ,and PM360 Pharma Choice Awards Programs. ... ... -- Chicago-based full-service healthcare communications agency Goble & Associates, Inc. ... honoring exceptional creative and interactive work. , , ,THE RX ... Awards of Excellence for the following creative work: Hospira LifeShield ...
Breaking Biology Technology:Osteotech Submits 510(k) Application to FDA for Clearance of its Duratech(TM) BioRegeneration Matrix 2Osteotech Submits 510(k) Application to FDA for Clearance of its Duratech(TM) BioRegeneration Matrix 3For the First Time, a Glioma ¨C Brain Cancer ¨C may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing 2For the First Time, a Glioma ¨C Brain Cancer ¨C may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing 3For the First Time, a Glioma ¨C Brain Cancer ¨C may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing 4The MedZilla Report for November 2009 - Healthcare Employment Up, And No Major Bad News for Pharma, Either 2The MedZilla Report for November 2009 - Healthcare Employment Up, And No Major Bad News for Pharma, Either 3Goble & Associates Creative Work Awarded at Advertising Industry Competitions 2Goble & Associates Creative Work Awarded at Advertising Industry Competitions 3Goble & Associates Creative Work Awarded at Advertising Industry Competitions 4
... 7 - Decision Taken to Advance ... ThromboGenics NV (Euronext Brussels: THR), a biotechnology company,focused ... Exchange: BINV), announce today that they have,successfully completed ... first Phase I trial of TB-402, which is ...
... Globally, approximately 418 billion,people are currently infected with ... hepatitis in the 21st century cannot be,understated or ... by Kalorama Information. Paradoxically, despite the obvious ... to contain hepatitis. Yet the incidence and,prevalence of ...
... N.J., Sept. 6 Pharmasset, Inc.,(Nasdaq: VRUS ... four scientific,presentations related to R7128 for the treatment ... at the 14th International Symposium on Hepatitis C,Virus ... 2007 in Glasgow,Scotland. R7128, a prodrug of PSI-6130, ...
Other Biology Technology:ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 2ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 3ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 4ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 5Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health 2Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses 2Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses 3Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses 4Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses 5
(Date:12/16/2009)... Athletes, superstitions and rituals can help them get psyched ... anti-inflammatory drugs (NSAIDs), which many athletes gobble down before ... than good. , "These agents are treatments for the ... Stuart Warden, whose research at Indiana University focuses on ... athlete to exercise or train at a certain level, ...
(Date:12/16/2009)... 15, 2009 Signal Hill, CA Tom Bowman, ... and president of Bowman Global Change, has developed a ... fourth Intergovernmental Panel on Climate Change (IPCC) report for ... the authentic scientific information they need to make informed ... created the new format as a means to clearly ...
(Date:12/16/2009)... Dec. 1 GestureTek Inc. today ... 3.0 - a turnkey, portable, plug and ... exhibits, entertainment and touring promotions. GestureTek is ... patents in camera-enabled gesture recognition technology for ... Guaranteed for quality, the CUBE has TUV, ...
Breaking Biology News(10 mins):NSAIDs: Take 'em early and often when competing? Think again 2Bowman creates graphic translation of climate change data 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3Statement of Robert Greenstein Executive Director Center on Budget and Policy Priorities on The Senate Finance Committees Health Reform Plan 59410 1Statement of Robert Greenstein Executive Director Center on Budget and Policy Priorities on The Senate Finance Committees Health Reform Plan 59410 2Statement of Robert Greenstein Executive Director Center on Budget and Policy Priorities on The Senate Finance Committees Health Reform Plan 59410 3Americans United for Lifes Statement on Finance Committee Vote 59407 1XLHealth Applauds Quality Focused Reforms in Senate Finance Committee Legislation 59404 1XLHealth Applauds Quality Focused Reforms in Senate Finance Committee Legislation 59404 2
... genetic information concerning the long-disputed origin of the ... University of La Laguna, and the International Potato ... remnants of the earliest known landraces of the ... They report their findings in the May-June 2007 ...
... Keeping at arm's length won't protect you from catching ... University of Technology which reveals airborne viruses can spread ... QUT's International Laboratory for Air Quality and Health, said ... humans only travel a metre in the air. ...
... creatures that live in the deepest parts of the Pacific ... the unlikeliest of habitats ?the carcass of a dead whale. ... sea anemone isn't so unusual. But finding one that calls ... apart. , Since the scientists who initially found these ...
Other Biology News:Spud origin controversy solved 2Spreading viruses as we breathe 2From the deep -- Researchers find new species of sea anemone 2From the deep -- Researchers find new species of sea anemone 3
... internal standard for the quantification of 5-OxoETE ... is a polyunsaturated keto acid formed by ... It stimulates cytosolic calcium levels in neutrophils ... selectively stimulates the migration and degranulation of ...
... consists of ten double-stranded RNAs, 10, 20, ... and 1,000 base pairs. The dsRNA Marker ... sizes of double-stranded RNAs. A twenty bp ... is adjusted to approximately 25 ng/µl in ...
... off-white solid. A nucleoside antibiotic that ... formation of N-glycosidic protein-carbohydrate linkages. Active ... bacteria, yeasts, fungi, and viruses. Inhibits ... on human T-lymphoblastoid cells. Also inhibits ...
... a group of enzymes involved in matrix ... metalloproteinase family ten exist in soluble form ... MT1-MMP, MT2-MMP, MT3-MMP also known as MMP14, ... domain anchoring them to the cell surface. ...
Biology Products: